Hrt Financial LP Compugen LTD Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.75 - $2.95 $287,087 - $483,947	164,050 Added 1011.53%	180,268 $465,000
Q4 2023 Feb 09, 2024	BUY	$0.53 - $2.0 $8,595 - $32,436	16,218 New	16,218 $32,000
Q3 2022 Nov 14, 2022	BUY	$0.66 - $2.32 $16,513 - $58,046	25,020 New	25,020 $16,000
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $349,918 - $588,268	-126,782 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $518,538 - $907,759	126,782 New	126,782 $545,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $104,286 - $139,048	-15,180 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $116,430 - $209,028	15,180 New	15,180 $130,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.